# Healthcare Triangle, Inc.: filings

HCTI · Nasdaq · CIK 1839285 · [Technology](/sectors/technology.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/hcti.md) · [Financials](/companies/hcti/financials.md) · [Filings](/companies/hcti/filings.md) · [Insiders](/companies/hcti/insiders.md)

## Reports and events: 118 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (8-K 64, CORRESP 21, 3 18, 4 18, 10-Q 15, 5 12, S-1/A 10, UPLOAD 10, EFFECT 9, DEF 14A 8, PRE 14A 7, 10-K 5, 8-K/A 5, S-1 5, PRE 14C 4, S-3 4, 10-K/A 3, 424B5 3, D 3, DEF 14C 3, NT 10-Q 3, SCHEDULE 13G 3, SCHEDULE 13G/A 3, 424B3 2, 424B4 2, DRS 2, DRS/A 2, DRSLTR 2, S-3/A 2, 10-Q/A 1, 3/A 1, 4/A 1, 8-A12B 1, ARS 1, CERT 1, D/A 1, DEFR14A 1, FWP 1, NT 10-K 1, POS AM 1, RW 1, SC 13D 1, SC 13D/A 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-23 | 17:20 ET | [8-K](/filings/0001213900-26-112193.md) | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001213900-26-112193 |
| 2026-10-13 | 17:20 ET | [DEF 14A](/filings/0001213900-26-109104.md) | Proxy statement, period 2026-10-23 | 0001213900-26-109104 |
| 2026-10-02 | 17:20 ET | [8-K](/filings/0001213900-26-106533.md) | 3.01 Delisting notice; 9.01 Financial statements and exhibits | 0001213900-26-106533 |
| 2026-09-25 | 17:15 ET | [8-K](/filings/0001213900-26-103604.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001213900-26-103604 |
| 2026-09-08 | 13:56 ET | [8-K](/filings/0001213900-26-097953.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001213900-26-097953 |
| 2026-08-13 | 17:16 ET | [10-Q](/filings/0001213900-26-089241.md) | Quarterly report, period 2026-06-30 | 0001213900-26-089241 |
| 2026-07-29 | 07:10 ET | [8-K](/filings/0001213900-26-082514.md) | 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-26-082514 |
| 2026-07-20 | 16:05 ET | [8-K](/filings/0001213900-26-079616.md) | 5.07 Shareholder vote results | 0001213900-26-079616 |
| 2026-07-10 | 17:15 ET | [S-1](/filings/0001213900-26-077268.md) | Registration statement | 0001213900-26-077268 |
| 2026-06-26 | 17:00 ET | [DEF 14A](/filings/0001213900-26-072691.md) | Proxy statement, period 2026-07-17 | 0001213900-26-072691 |
| 2026-06-26 | 16:45 ET | [8-K](/filings/0001213900-26-072674.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001213900-26-072674 |
| 2026-06-15 | 17:00 ET | [8-K](/filings/0001213900-26-068871.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-26-068871 |
| 2026-05-14 | 20:19 ET | [10-Q](/filings/0001213900-26-056096.md) | Quarterly report, period 2026-03-31 | 0001213900-26-056096 |
| 2026-04-16 | 16:47 ET | [10-K/A](/filings/0001213900-26-044671.md) | Annual report, amended, period 2025-12-31 | 0001213900-26-044671 |
| 2026-04-15 | 16:23 ET | [10-K](/filings/0001213900-26-044078.md) | Annual report, period 2025-12-31 | 0001213900-26-044078 |
| 2026-04-10 | 17:15 ET | [8-K](/filings/0001213900-26-042597.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001213900-26-042597 |
| 2026-04-07 | 17:05 ET | [8-K/A](/filings/0001213900-26-041119.md) | 9.01 Financial statements and exhibits | 0001213900-26-041119 |
| 2026-03-11 | 16:30 ET | [8-K](/filings/0001213900-26-026181.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-26-026181 |
| 2026-02-27 | 17:00 ET | [8-K](/filings/0001213900-26-021740.md) | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-26-021740 |
| 2026-02-13 | 16:01 ET | [8-K](/filings/0001213900-26-016390.md) | 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-26-016390 |
| 2026-02-06 | 16:01 ET | [8-K](/filings/0001213900-26-013262.md) | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001213900-26-013262 |
| 2026-01-28 | 10:03 ET | [8-K](/filings/0001213900-26-008594.md) | 1.01 Entry into a material agreement; 2.01 Completion of an acquisition or disposition; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-26-008594 |
| 2026-01-20 | 10:26 ET | [DEF 14A](/filings/0001213900-26-005400.md) | Proxy statement, period 2026-02-02 | 0001213900-26-005400 |
| 2025-12-10 | 09:00 ET | [8-K](/filings/0001213900-25-119878.md) | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-25-119878 |
| 2025-12-02 | 16:10 ET | [8-K](/filings/0001213900-25-117252.md) | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001213900-25-117252 |
| 2025-11-21 | 16:57 ET | [8-K](/filings/0001213900-25-113672.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001213900-25-113672 |
| 2025-11-19 | 14:27 ET | [8-K](/filings/0001213900-25-112546.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001213900-25-112546 |
| 2025-11-17 | 09:43 ET | [DEF 14A](/filings/0001213900-25-111526.md) | Proxy statement, period 2025-11-28 | 0001213900-25-111526 |
| 2025-11-13 | 08:01 ET | [10-Q](/filings/0001213900-25-109581.md) | Quarterly report, period 2025-09-30 | 0001213900-25-109581 |
| 2025-11-10 | 16:01 ET | [8-K](/filings/0001213900-25-108196.md) | 5.07 Shareholder vote results | 0001213900-25-108196 |
| 2025-10-15 | 16:01 ET | [DEF 14A](/filings/0001213900-25-099128.md) | Proxy statement, period 2025-11-07 | 0001213900-25-099128 |
| 2025-10-08 | 17:00 ET | [8-K](/filings/0001213900-25-097464.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 3.03 Change to security holders’ rights; 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-25-097464 |
| 2025-09-15 | 17:00 ET | [8-K](/filings/0001213900-25-087694.md) | 3.01 Delisting notice; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-25-087694 |
| 2025-09-02 | 17:52 ET | [8-K/A](/filings/0001213900-25-082708.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001213900-25-082708 |
| 2025-08-14 | 16:18 ET | [10-Q](/filings/0001213900-25-076686.md) | Quarterly report, period 2025-06-30 | 0001213900-25-076686 |
| 2025-08-01 | 17:15 ET | [8-K](/filings/0001213900-25-070705.md) | 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-25-070705 |
| 2025-07-07 | 09:15 ET | [8-K](/filings/0001213900-25-061649.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-25-061649 |
| 2025-06-23 | 17:13 ET | [8-K](/filings/0001213900-25-056774.md) | 1.01 Entry into a material agreement; 2.01 Completion of an acquisition or disposition; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-25-056774 |
| 2025-05-30 | 17:26 ET | [8-K](/filings/0001213900-25-049571.md) | 3.01 Delisting notice | 0001213900-25-049571 |
| 2025-05-23 | 17:11 ET | [8-K](/filings/0001213900-25-047425.md) | 3.01 Delisting notice | 0001213900-25-047425 |
| 2025-05-20 | 16:30 ET | [10-Q](/filings/0001213900-25-045994.md) | Quarterly report, period 2025-03-31 | 0001213900-25-045994 |
| 2025-05-09 | 21:33 ET | [S-1/A](/filings/0001213900-25-041190.md) | Registration statement, amended | 0001213900-25-041190 |
| 2025-04-22 | 16:57 ET | [S-1/A](/filings/0001213900-25-034248.md) | Registration statement, amended | 0001213900-25-034248 |
| 2025-04-11 | 17:29 ET | [8-K](/filings/0001213900-25-031182.md) | 4.01 Change of auditor; 9.01 Financial statements and exhibits | 0001213900-25-031182 |
| 2025-04-11 | 08:45 ET | [8-K](/filings/0001213900-25-030806.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001213900-25-030806 |
| 2025-04-02 | 16:01 ET | [8-K](/filings/0001213900-25-027987.md) | 5.07 Shareholder vote results | 0001213900-25-027987 |
| 2025-04-01 | 11:40 ET | [S-1](/filings/0001213900-25-027277.md) | Registration statement | 0001213900-25-027277 |
| 2025-03-31 | 16:01 ET | [10-K](/filings/0001213900-25-026218.md) | Annual report, period 2024-12-31 | 0001213900-25-026218 |
| 2025-03-24 | 16:01 ET | [8-K](/filings/0001013762-25-001582.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001013762-25-001582 |
| 2025-03-07 | 07:00 ET | [DEF 14A](/filings/0001213900-25-021346.md) | Proxy statement, period 2025-03-28 | 0001213900-25-021346 |

Page 1 of 3. [Older](/companies/hcti/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 27, 2026, 17:16 ET. No prices; not investment advice.